Chair's Address to Shareholders

The 2025 financial year presented us with challenges with continued changes to the European product registration requirements, instability in some Middle East markets and underperforming Asian markets. Despite this, product margins increased, and operating expenses were well managed, giving a solid normalized after-tax profit of $10.5 million, up 0.1% on last year. Our sales of $110.4 million were